Non-invasive biomarkers: Promising future to reduce patients’ burden and accelerate drug development in MASH

Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?

Discover how innovation in complex clinical trial design can address growing clinical trial complexity and improve productivity in drug development.

Regulatory intelligence in action: Transforming compliance into strategy

Marcus Stavchansky

Stavchansky is Executive Director and Global Head of Pharmacy Services at Fortrea, based in Dallas, Texas.

In-clinic cGMP Pharmacies

Accelerate Phase 1 clinical trials with Fortrea’s on-site cGMP pharmacies. Small-batch drug manufacturing ensures quality, safety, and cost savings.

Project Optimus: The evolution of dose optimisation in oncology

Project Optimus seeks to transform how doses are selected and optimised in oncology drug development.

Leveraging community-based clinical trial sites to expand oncology research access

This article reviews the concept of a commuity site and explores the current barriers limiting involvement of community sites in clinical trials.

Intelligent innovation at Fortrea: How AI is transforming clinical research

How is Fortrea leveraging artificial intelligence to enhance clinical research while maintaining a human-centered, collaborative and scalable approach?

Overcoming challenges in a complex Phase IIb pain clinical trial

How can a CRO accelerate recruitment and improve retention in pain studies with complex measurement challenges?